Clinical Trial Update: Rett REVOLUTION Trial: An Exploratory Evaluation of the Safety and Efficacy of Vorinostat in Rett Syndrome [Phase 1]

View source ↗

Summary

This update covers a Phase 1 exploratory trial (Rett REVOLUTION) evaluating vorinostat for Rett syndrome, which is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rett Syndrome

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: Unravel Biosciences, Inc. | Conditions: Rett Syndrome | Phase 1 | Status: NOT_YET_RECRUITING